-
Most Popular
Search Results
240 results for MER
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Welcome back, trader! We’re kicking off the week with a look at the biggest pre-market stock movers you need to know about for Monday!
Investors Should Buy Alcoa — Through XLB
If you are interested in preserving capital, think twice about investing in a single stock — instead choose a basket of stocks in the same…
The Overblown Squarepocalypse Melodrama Won’t Stop Square Stock
Square stock may have incurred some negative press from raising its merchant transaction costs, but the overall picture for the company remains bright.
Will Stagflation Hit the Stock Market in 2022? Here’s What Experts Have to Say.
Investors and analysts everywhere are abuzz lately as whispers of stagflation fill the markets. Is stagflation coming?
ARDS Stock Alert: The Covid-19 News Sending Aridis Skyrocketing Today
Aridis Pharmaceuticals has a new cocktail, and it may be the ticket out of the omicron variant. Here’s why ARDS stock is worth watching.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
InvestorPlace is starting the day off right by checking out the biggest pre-market stock movers, including the winners and losers.
INO Stock May Fade After the Virus, but It Could Rocket to $20 First
With phase one of human trials underway, we may be closer than ever to putting the virus to bed. Before that happens, INO stock will…
Merck and Biotech’s Swashbuckling Era
MRK stock has entered a new swashbuckling era, searching for new profit gushers like Keytruda, the company’s anti-cancer drug.
Today’s Biggest Pre-Market Movers: 10 Top Gainers and Losers on Friday Morning
The weekend is almost here but investors have one more day of trading and we’re helping out with the biggest pre-market movers for Friday.
Today’s Biggest Pre-Market Movers: 10 Top Gainers and Losers on Monday Morning
It’s the start of a new week and InvestorPlace is kicking it off with a look at the biggest pre-market movers for Monday morning.
A Strategy for a Confounding Market
The near-term downtrend is intact, but the markets’ unpredictable responses to news yesterday, threw a monkey wrench into the works.
Initial Coronavirus Treatment Trials Look Good for Gilead Stock
GILD stock is getting a boost from early trials of its remdesivir drug, which is showing some promise in treating the novel coronavirus.
5 Plays 3M’s New CEO Must Run to Win
As CEO Buckley hands over the reins, the stakes are high for 3M to get this changing of the guard right.
Opportunity Knocks: 3 Large-Cap Stocks to Buy at 52-Week Lows
Uncover investment opportunities with these large-cap stocks at 52-week lows. See why these beaten-down giants are set for a strong recovery.
New GERM ETF Debuts at Just the Right Time
The race for a Covid-19 vaccine will bring eyes to the new GERM ETF, but there’s long-term available here, too.
Gilead’s Coronavirus Drug Could Propel GILD Stock Much Higher
Gilead’s coronavirus drug could propel GILD stock much higher. If Gilead’s coronavirus drug remdesivir has successful trials, GILD stock could skyrocket.
Gilead Stock Flies High With a Potential Coronavirus Treatment
GILD stock could skyrocket if it is first in the door to provide an effective treatment for the coronavirus with its remdesivir drug.
Which China ETF is Right For You?
The best way to get exposure to China’s value is through exchange-traded funds. Here are three China ETFs investors should consider picking up.
An Investor’s Guide to Housing’s Courtroom Dramas
Lawsuits are joining jobs and the economy as a major weight on housing. Here are some key legal issues investors need to monitor.
5 – 10 of 240 results
